-
SBI Healthcare Opportunities Fund Regular Growth
Equity healthcare
Overview ( as on 23/06/26 )
NAV
₹483.58
Last change
₹1.32 +0.0%
Fund Size (AUM)
4565.95 Cr
Performance
16.63% (5Y)
Fund Details
SBI Healthcare Opportunities Fund Regular Growth
as of 23/06/26
AUM
4565.95 Cr
Expense Ratio
1.88 %
Benchmark
BSE Healthcare TR INR
ISIN
INF200K01446
Fund Manager
Tanmaya Desai
Exit Load
0.5% if redeemed within 0-15 days
0% if redeemed after 15 days
| Fund Performance | 1Y | 3Y | 5Y |
|---|---|---|---|
| SBI Healthcare Opportunities Fund Regular Growth | 15.78% | 24.4% | 16.63% |
| BSE Healthcare TR INR | 9.86% | 25.5% | 13.79% |
Top 10 Holdings
Sun Pharmaceuticals Industries Ltd |
11.03% |
Divi's Laboratories Ltd |
6.57% |
Acutaas Chemicals Ltd |
6.17% |
Apollo Hospitals Enterprise Ltd |
5.37% |
Max Healthcare Institute Ltd Ordinary Shares |
4.76% |
Aurobindo Pharma Ltd |
3.9% |
Aster DM Healthcare Ltd Ordinary Shares |
3.83% |
Laurus Labs Ltd |
3.58% |
Biocon Ltd |
3.52% |
Torrent Pharmaceuticals Ltd |
3.48% |
Sector Allocation
Healthcare |
90.95% |
Basic Materials |
9.05% |
Asset Allocation
-
97%
Equity
-
2%
Others
-
0%
Debt
Risk and Return Category
Risk v/s Category
-
Low
-
Below Average
-
Average
-
Above Average
-
High
Return v/s Category
-
Low
-
Below Average
-
Average
-
Above Average
-
High
Related Funds
-
ICICI Pru Pharma Healthcare Diag Fund
Equity healthcare-
Returns
-
16.27% (5Y)
-
-
UTI Healthcare Fund
Equity healthcare-
Returns
-
14.92% (5Y)
-
-
UTI Healthcare IDCW-P Fund
Equity healthcare-
Returns
-
14.92% (5Y)
-
-
UTI Healthcare IDCW-R Fund
Equity healthcare-
Returns
-
14.92% (5Y)
-
-
ICICI Pru Pharma Healthcare Dg IDCW-R Fund
Equity healthcare-
Returns
-
15.61% (5Y)
-
-
SBI Healthcare Opportunities Fund
Equity healthcare-
Returns
-
16.63% (5Y)
-
